PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias

This study has been terminated.
(Drug supply discontinued by Collaborator.)
Sponsor:
Collaborator:
Genzyme, a Sanofi Company
Information provided by (Responsible Party):
UNC Lineberger Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT01169012
First received: July 22, 2010
Last updated: January 20, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: July 2016
  Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)